CN Patent

CN107029208A — 一种治疗心血管疾病的赖诺普利复方制剂及其制备方法

Assigned to HUANGHE PHARMACEUTICAL INDUSTRY Co Ltd JIANGSU · Expires 2017-08-11 · 9y expired

What this patent protects

本发明涉及治疗心血管疾病的复方制剂，尤其涉及一种治疗心血管疾病的赖诺普利复方制剂，包括以下重量份的药物：赖诺普利2～6份、氢氯噻嗪0.8～2.8份、苯磺酸左旋氨氯地平1.6～3.6份，本发明根据联合用药充分发挥药物互补的作用机制增加疗效，快速达标，使血压达标率达到82％，减少与某一剂量增大相关的不良反应。本发明复合制剂具有见效快，血压达标率高，副作用小，成本低的特点。

USPTO Abstract

本发明涉及治疗心血管疾病的复方制剂，尤其涉及一种治疗心血管疾病的赖诺普利复方制剂，包括以下重量份的药物：赖诺普利2～6份、氢氯噻嗪0.8～2.8份、苯磺酸左旋氨氯地平1.6～3.6份，本发明根据联合用药充分发挥药物互补的作用机制增加疗效，快速达标，使血压达标率达到82％，减少与某一剂量增大相关的不良反应。本发明复合制剂具有见效快，血压达标率高，副作用小，成本低的特点。

Drugs covered by this patent

Patent Metadata

Patent number
CN107029208A
Jurisdiction
CN
Classification
—
Expires
2017-08-11
Drug substance claim
No
Drug product claim
No
Assignee
HUANGHE PHARMACEUTICAL INDUSTRY Co Ltd JIANGSU
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.